Camber Pharmaceuticals Recalls Antifungal Drug Due to Contamination Risk
Pharma Leaders
APRIL 4, 2023
Camber Pharmaceuticals has recalled one lot of Atovaquone oral suspension, USP 750mg/5mL because of the possible contamination with Bacillus cereus — bacteria found in soil, plants and food. The affected lot was distributed nationwide, but the company has not received any reports of adverse events related to the issue.
Let's personalize your content